One-Fourth of Myriad’s Variants of Unknown Significance Reclassified Over 10 Years
From - Diagnostic Testing & Emerging Technologies
Variant reclassification following hereditary cancer genetic testing is common, according to a study published by…
This content is for Paid Members only.
Register
Register
Already a member? Log in here
